• Lutte contre les cancers

  • Qualité de vie, soins de support

Physiologic Frailty and Neurocognitive Decline Among Young-Adult Childhood Cancer Survivors: A Prospective Study From the St Jude Lifetime Cohort

Menée aux Etats-Unis à partir de données portant sur des jeunes adultes ayant survécu à un cancer pédiatrique (âge : 18-45 ans), cette étude analyse l'association entre une fragilité physiologique (perte musculaire, faiblesse musculaire, faible dépense énergique, marche lente, etc.) et une diminution des capacités neurocognitives

PURPOSE : Eight percent of young-adult childhood cancer survivors meet criteria for frailty, an aging phenotype associated with poor health. In the elderly general population, frailty is associated with neurocognitive decline; this association has not been examined in adult survivors of childhood cancer. METHODS : Childhood cancer survivors 18-45 years old (≥ 10 years from diagnosis) were clinically evaluated for prefrailty or frailty (respectively defined as ≥ 2 or ≥ 3 of: muscle wasting, muscle weakness, low energy expenditure, slow walkimpling probability estimates as weights compared differences in neurocognitive decline in prefrail and frail survivors versus nonfrail survivors, adjusting for diagnosis age, sex, race, CNS–directed therapy (cranial radiation, intrathecal chemotherapy, and neurosurgery), and baseline neurocognitive performance. RESULTS : Survivors were on average 30 years old and 22 years from diagnosis; 18% were prefrail and 6% frail at enrollment. Frail survivors declined an average of 0.54 standard deviation (95% CI, −0.93 to −0.15) in short-term verbal recall, whereas nonfrail survivors did not decline (

β = .22; difference of βs =

−.76; 95% CI, −1.19 to −0.33). Frail survivors declined more than nonfrail survivors on visual-motor processing speed (

β =

−.40; 95% CI, −0.67 to −0.12), cognitive flexibility (

β =

−.62; 95% CI, −1.02 to −0.22), and verbal fluency (

β =

−.23; 95% CI, −0.41 to −0.05). Prefrail and frail survivors experienced greater declines in focused attention (prefrail

β =

−.35; 95% CI, −0.53 to −0.17; frail

β =

−.48; 95% CI, −0.83 to −0.12) compared with nonfrail survivors. CONCLUSION : Over approximately 5 years, prefrail and frail young-adult survivors had greater declines in cognitive domains associated with aging and dementia compared with nonfrail survivors. Interventions that have global impact, designed to target the mechanistic underpinnings of frailty, may also mitigate or prevent neurocognitive decline.

Journal of Clinical Oncology

Voir le bulletin